CRONHIGH SIGNALFINANCIAL10-K

Cronos Group reported substantially improved operating performance with meaningful reduction in operating losses despite revenue growth of 25%.

The company's operating income improved dramatically from -$76.5M to -$17.4M, indicating significantly better operational efficiency and cost management execution. Combined with strong revenue growth and positive operating cash flow generation, this suggests the cannabis company is making substantial progress toward profitability after years of losses.

Comparing 2026-02-26 vs 2025-02-27View on EDGAR →
FINANCIAL ANALYSIS

Cronos delivered strong financial performance across key metrics, with revenue growing 25% to $146.6M while operating losses narrowed substantially from -$76.5M to -$17.4M. Operating cash flow remained positive and grew 37% to $25.9M, while inventory increased 41% to $46.8M, likely supporting the revenue growth trajectory. The combination of top-line expansion with dramatically improved operating leverage suggests meaningful operational improvements and progress toward sustainable profitability.

FINANCIAL STATEMENT CHANGES
Operating Income
P&L
+77.3%
-$76.5M→-$17.4M

Operating leverage kicking in — revenue growth outpacing cost growth, a hallmark of scaling businesses.

Interest Expense
P&L
-51.9%
$27K→$13K

Interest expense declined — debt repayment or refinancing at lower rates improving earnings quality.

Inventory
Balance Sheet
+41%
$33.1M→$46.8M

Inventory surged 41% — growing faster than typical sales pace; potential demand softening or supply chain overcorrection.

Operating Cash Flow
Cash Flow
+37.3%
$18.8M→$25.9M

Operating cash flow surged 37.3% — exceptional cash generation, highest quality earnings signal.

Revenue
P&L
+24.6%
$117.6M→$146.6M

Revenue growing 24.6% — solid top-line momentum, watch margins for quality of growth.

LANGUAGE CHANGES
NEW — 2026-02-26
PRIOR — 2025-02-27
ADDED
As of February 23, 2026, there were 379,051,102 common shares of the Registrant issued and outstanding.
Exhibits, Financial Statement Schedules 123 Unless otherwise noted or the context indicates otherwise, references in this Annual Report on Form 10-K (this Annual Report ) to the Company, Cronos, we, us and our refer to Cronos Group Inc., its direct and indirect wholly owned subsidiaries and, if applicable, its joint ventures and investments accounted for by the equity method; the term cannabis means the plant of any species or subspecies of genus Cannabis and any part of that plant, including all derivatives, extracts, cannabinoids, isomers, acids, salts, and salts of isomers; the term U.S.
(Exchange rates are shown as C$ per $) As of December 31, 2025 2024 2023 Average rate 1.3975 1.3700 1.3494 Spot rate 1.3698 1.4351 1.3243 (Exchange rates are shown as ILS per $) As of December 31, 2025 2024 2023 Average rate 3.4432 3.6997 3.6819 Spot rate 3.1863 3.6526 3.6163 All summaries of agreements described herein are qualified by the full text of such agreements (certain of which are filed as exhibits hereto).
In some cases, Forward-Looking Statements can be identified by the use of forward-looking terminology, such as expect, likely, may, will, should, intend, anticipate, potential, proposed, estimate, believe, plan and other similar words, expressions and phrases, including negative and grammatical variations thereof, or statements that certain events or conditions may or will happen, or by discussion of strategy.
( High Tide ), as borrower, and a warrant (the High Tide Warrant ) to purchase common shares of High Tide, the performance of the High Tide Loan and the High Tide Warrant, and High Tide s ability to repay the High Tide Loan; expectations related to our agreement to acquire CanAdelaar B.V.
+7 more — sign up free →
REMOVED
As of February 24, 2025, there were 382,530,780 common shares of the Registrant issued and outstanding.
(Exchange rates are shown as C$ per $) As of December 31, 2024 2023 2022 Average rate 1.3700 1.3494 1.3017 Spot rate 1.4351 1.3243 1.3554 (Exchange rates are shown as ILS per $) As of December 31, 2024 2023 2022 Average rate 3.6997 3.6819 3.3566 Spot rate 3.6526 3.6163 3.5178 All summaries of agreements described herein are qualified by the full text of such agreements (certain of which are filed as exhibits hereto).
In some cases, Forward-Looking Statements can be identified by the use of forward-looking terminology, such as expect , likely , may , will , should , intend , anticipate , potential , proposed , estimate and other similar words, expressions and phrases, including negative and grammatical variations thereof, or statements that certain events or conditions may or will happen, or by discussion of strategy.
s investment in the Company (the Altria Investment ), pursuant to a subscription agreement dated December 7, 2018; uncertainties as to our ability to exercise our option (the PharmaCann Option ) in PharmaCann Inc.
( PharmaCann ), in the near term or the future, in full or in part, including the uncertainties as to the status and future development of federal legalization of cannabis in the U.S.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →